Higher vs. Lower Dose Heparin for PCI
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPopulation Health Research Institute
About this trial
HD PCI is a multicenter, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI).
Eligibility criteria
Qualifiers
None
Disqualifiers
Age <18 years
Planned chronic total occlusion PCI
Non-resident precluding follow up through local registries
Submit PCI procedure data to a compatible registry that is able to provide data for the trial
Trial design
Treatments tested in this trial
- Higher Dose UFH
- Lower Dose UFH
Treatment groups
16,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov